The Trump administration has revised routine childhood vaccine recommendations, focusing on 11 diseases and prompting criticism from health professionals over safety and policy implications amid ongoing debates on immunisation practices.
The Trump administration has sharply narrowed the federal government’s routine childhood vaccine recommendations, recasting universal guidance around 11 diseases and prompting a fresh clash with doctors and public health groups over how far Washington should go in reshaping immunisation policy. According to the White House and the Centres for Disease Control and Prevention, the new framework grew out of a scientific review ordered by Donald Trump and aimed at aligning US practice more closely with peer developed countries while preserving access to existing vaccines. The shift was first set in motion earlier this year, when federal officials said the routine category would cover 11 diseases after reviewing childhood schedules in other advanced economies.
The change does not mean children will receive only 11 injections, nor does it mean the previous federal schedule contained 72 separate vaccines. Trump used the larger number in remarks promoting the overhaul, but the figure referred to doses rather than distinct products. Under the revised approach, vaccines for hepatitis A, hepatitis B, meningococcal disease, dengue and RSV monoclonal antibodies are placed in a higher-risk category, while several others, including influenza and COVID-19, fall under shared clinical decision-making, meaning families and clinicians decide together whether to use them. The White House order also says the combined measles, mumps and rubella vaccine should eventually be replaced by three separate shots once those products are available in the United States, and that childhood immunisations should be spaced out across separate medical visits where possible.
That last instruction has already drawn scepticism. CBS News medical correspondent Dr. Céline Gounder said the standalone MMR option does not exist in the United States because Merck stopped making individual measles, mumps and rubella vaccines in 2009 and no company has said it is preparing one. The order also directs the Department of Health and Human Services to review the timing and sequencing of childhood vaccines within 90 days, while the HHS task force on safer childhood vaccines is told to examine alternatives to aluminium adjuvants and to continue work on safety monitoring and research.
The politics around the overhaul remain fierce. Trump tied the policy to autism in his remarks, even though the executive order does not cite autism as a basis for the new categories. Existing research does not support a link between MMR vaccination and autism, including a 2015 study of more than 95,000 children and a 2019 Danish study of more than 650,000 children. The American Academy of Pediatrics continues to recommend routine vaccination against 18 diseases in its 2026 schedule, arguing that US policy should not simply mirror other countries because risks, demographics, health systems and vaccine access differ. Republican Senator Bill Cassidy, a doctor, was even more blunt, calling the order wrong and warning that splitting vaccines would mean more shots, not fewer. For parents, the practical effect is not the removal of every vaccine outside the 11-disease core, but a new federal framework that distinguishes universal recommendations from vaccines reserved for higher-risk groups or individual discussion.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
